Frost Insights: Discerning Biotech Bankruptcies in 2023
Frost & Sullivan
JUNE 11, 2024
Biotech bankruptcies reached a record high in 2023 with over 20 companies announcing insolvency. Financial struggles in a post-COVID-19 economy and rising inflation have adversely impacted the global biotech industry. Large pharma companies need to innovate quickly to off-set emerging losses due to patent expiration.
Let's personalize your content